Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma

BACKGROUND: This study aimed to evaluate the efficacy and safety of rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treating patients with diffuse large B-cell lymphoma (DLBCL). METHODS: A total of 144 patients with DLBCL were randomly divided into int...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Hu, Xin, Zeng, Min, Yang, Shun-e, Liang, Xiao, Ding, Shan-shan, Guo, Li, Li, Shan, Wen, Shu-juan
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2017
Témata:
3800
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5690734/
https://ncbi.nlm.nih.gov/pubmed/29137041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000008494
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky